ArticleNeuropsychiatric disease and treatment2019

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study.

Hsinsung Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.